# An Observational Study of Adherence to Anastrozole in Early Breast Cancer Treatment

> **NCT00737009** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 259 (actual)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00737009
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 259 (ACTUAL)
- **Last updated:** 2011-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00737009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00737009, "An Observational Study of Adherence to Anastrozole in Early Breast Cancer Treatment". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00737009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*